DNA vaccines against viral diseases of farmed fish

Fish Shellfish Immunol. 2013 Dec;35(6):1751-8. doi: 10.1016/j.fsi.2013.10.021. Epub 2013 Oct 31.

Abstract

Immunization by an antigen-encoding DNA was approved for commercial sale in Canada against a Novirhabdovirus infection in fish. DNA vaccines have been particularly successful against the Novirhabdoviruses while there are reports on the efficacy against viral pathogens like infectious pancreatic necrosis virus, infectious salmon anemia virus, and lymphocystis disease virus and these are inferior to what has been attained for the novirhabdoviruses. Most recently, DNA vaccination of Penaeus monodon against white spot syndrome virus was reported. Research efforts are now focused on the development of more effective vectors for DNA vaccines, improvement of vaccine efficacy against various viral diseases of fish for which there is currently no vaccines available and provision of co-expression of viral antigen and immunomodulatory compounds. Scientists are also in the process of developing new delivery methods. While a DNA vaccine has been approved for commercial use in farmed salmon in Canada, it is foreseen that it is still a long way to go before a DNA vaccine is approved for use in farmed fish in Europe.

Keywords: Basic concepts; DNA vaccination; Finfish; Review; Viral infections.

Publication types

  • Review

MeSH terms

  • Animals
  • Aquaculture
  • Fish Diseases / therapy*
  • Fish Diseases / virology
  • Fishes
  • Vaccines, DNA / therapeutic use*
  • Virus Diseases / therapy
  • Virus Diseases / veterinary*
  • Virus Diseases / virology

Substances

  • Vaccines, DNA